Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2). Issue 2 (2nd May 2022)
- Record Type:
- Journal Article
- Title:
- Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2). Issue 2 (2nd May 2022)
- Main Title:
- Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2)
- Authors:
- Karmakar, Shilpita
Ramirez, Oscar
Paul, Kiran V
Gupta, Abhishek K
Kumari, Vandana
Botti, Valentina
de los Mozos, Igor Ruiz
Neuenkirchen, Nils
Ross, Robert J
Karanicolas, John
Neugebauer, Karla M
Pillai, Manoj M - Abstract:
- Abstract: Musashi 2 (MSI2) is an RNA binding protein (RBP) that regulates asymmetric cell division and cell fate decisions in normal and cancer stem cells. MSI2 appears to repress translation by binding to 3′ untranslated regions (3′UTRs) of mRNA, but the identity of functional targets remains unknown. Here, we used individual nucleotide resolution cross-linking and immunoprecipitation (iCLIP) to identify direct RNA binding partners of MSI2 and integrated these data with polysome profiling to obtain insights into MSI2 function. iCLIP revealed specific MSI2 binding to thousands of mRNAs largely in 3′UTRs, but translational differences were restricted to a small fraction of these transcripts, indicating that MSI2 regulation is not triggered by simple binding. Instead, the functional targets identified here were bound at higher density and contain more 'UAG' motifs compared to targets bound nonproductively. To further distinguish direct and indirect targets, MSI2 was acutely depleted. Surprisingly, only 50 transcripts were found to undergo translational induction on acute loss. Using complementary approaches, we determined eukaryotic translation initiation factor 3A (EIF3A) to be an immediate, direct target. We propose that MSI2 downregulation of EIF3A amplifies these effects on translation. Our results also underscore the challenges in defining functional targets of RBPs since mere binding does not imply a discernible functional interaction. Graphical Abstract:
- Is Part Of:
- NAR cancer. Volumer 4:Issue 2(2022)
- Journal:
- NAR cancer
- Issue:
- Volumer 4:Issue 2(2022)
- Issue Display:
- Volume 4, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 4
- Issue:
- 2
- Issue Sort Value:
- 2022-0004-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-05-02
- Subjects:
- Cancer -- Periodicals
Cancer -- Genetic aspects -- Periodicals
Nucleic acids -- Periodicals
Molecular biology -- Periodicals
616.994 - Journal URLs:
- http://www.oxfordjournals.org/ ↗
https://academic.oup.com/narcancer ↗ - DOI:
- 10.1093/narcan/zcac015 ↗
- Languages:
- English
- ISSNs:
- 2632-8674
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21331.xml